Antiarrhythmics, Class Ic

DBCAT002518Therapeutic categoryC01BC

Pronounced reduction in phase 0 slope; no effect on APD (atrial premature depolarization) or ERP (effective refractory period). A DrugBank category of 8 drugs. 5 of them are approved.

ATC classification: C — CARDIOVASCULAR SYSTEM
C01 — CARDIAC THERAPY
C01B — ANTIARRHYTHMICS, CLASS I AND III
C01BC — Antiarrhythmics, class Ic
Part of: Antiarrhythmics, Class I
Also known as: Class 1 C Antiarrhythmics · Class 1C Antiarrhythmics · Class I C Antiarrhythmics · Class IC Antiarrhythmics · Class IC Antiarrythmics
Drugs: Ajmaline
Encainide
Ethacizine
Flecainide
Lorcainide
Moricizine
Prajmaline
Propafenone

What you can answer from here — as of August 13, 2018

8DrugsEach linked to its full drug card

Listed above

10Drug targetsEvery drug–target pair in the class, with bond type

584Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Antiarrhythmics, Class Ic share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account